[Is the Use of Placebo as Control Group in MS Drug Trials Still Appropriate?]

Nervenarzt. 2015 Apr;86(4):481-2. doi: 10.1007/s00115-015-4283-z.
[Article in German]

Publication types

  • Editorial

MeSH terms

  • Germany
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Multiple Sclerosis / drug therapy*
  • Outcome Assessment, Health Care / ethics*
  • Outcome Assessment, Health Care / methods*
  • Placebo Effect*
  • Randomized Controlled Trials as Topic / ethics*
  • Randomized Controlled Trials as Topic / methods

Substances

  • Immunosuppressive Agents